Literature DB >> 1598754

Cardiomyopathy in cattle induced by residues of the coccidiostat maduramicin in poultry litter given as a feedstuff.

A Shlosberg1, A Harmelin, S Perl, G Pano, M Davidson, U Orgad, U Kali, A Bor, M Van Ham, G Hoida.   

Abstract

An experimental feeding trial was conducted in order to substantiate an hypothesis on the aetiology of a previously unrecorded cardiomyopathic syndrome in beef cattle in Israel. It was believed that residues of the ionophore maduramicin (Cygro; American Cyanamid) in poultry litter fed to cattle, after the maduramicin had been incorporated into broiler feed as a coccidiostat, were the cause of the cardiomyopathy. Three groups of 5 heifers were fed for several weeks (1) poultry litter from a field case, containing 4.8 ppm maduramicin; (2) poultry litter to which maduramicin was added to give a concentration of 12 ppm; (3) poultry litter with no maduramicin (control). Clinical, biochemical, necropsy and histopathological findings showed that maduramicin residues are cardiotoxic, even at the lower level of maduramicin fed, which is commonly encountered in poultry litter in Israel.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1598754     DOI: 10.1007/bf01839204

Source DB:  PubMed          Journal:  Vet Res Commun        ISSN: 0165-7380            Impact factor:   2.459


  7 in total

1.  Cardiac failure in beef cattle fed dried poultry litter.

Authors:  S Perl; A Shlosberg; G Hoida; M Davidson; B Yakobson; U Orgad
Journal:  Vet Rec       Date:  1991-07-13       Impact factor: 2.695

Review 2.  Monensin toxicity in cattle.

Authors:  E L Potter; R L VanDuyn; C O Cooley
Journal:  J Anim Sci       Date:  1984-06       Impact factor: 3.159

3.  Outbreak of monensin poisoning in cattle.

Authors:  D D Wardrope; N S Macleod; J R Sloan
Journal:  Vet Rec       Date:  1983-06-11       Impact factor: 2.695

4.  Accidental monensin sodium intoxication of feedlot cattle.

Authors:  D Schweitzer; C Kimberling; T Spraker; F E Sterner; A E McChesney
Journal:  J Am Vet Med Assoc       Date:  1984-05-15       Impact factor: 1.936

5.  Clinical, clinicopathologic, and pathologic alterations in acute monensin toxicosis in cattle.

Authors:  J F Van Vleet; H E Amstutz; W E Weirich; A H Rebar; V J Ferrans
Journal:  Am J Vet Res       Date:  1983-11       Impact factor: 1.156

6.  The chronic course of a probable monensin toxicosis in cattle.

Authors:  A Shlosberg; S Perl; B Yakobson; U Klopfer; M N Egyed; T A Nobel; Y Efron
Journal:  Vet Hum Toxicol       Date:  1986-06

7.  Lasalocid toxicity in cattle: acute clinicopathological changes.

Authors:  S J Galitzer; F W Oehme; E E Bartley; A D Dayton
Journal:  J Anim Sci       Date:  1986-05       Impact factor: 3.159

  7 in total
  5 in total

1.  Maduramicin induces cardiac muscle cell death by the ROS-dependent PTEN/Akt-Erk1/2 signaling pathway.

Authors:  Xin Chen; Yue Li; Meng Feng; Xiaoyu Hu; Hai Zhang; Ruijie Zhang; Xiaoqing Dong; Chunxiao Liu; Zhao Zhang; Shanxiang Jiang; Shile Huang; Long Chen
Journal:  J Cell Physiol       Date:  2018-12-03       Impact factor: 6.384

2.  Maduramicin induces apoptosis and necrosis, and blocks autophagic flux in myocardial H9c2 cells.

Authors:  Xin Chen; Long Chen; Shanxiang Jiang; Shile Huang
Journal:  J Appl Toxicol       Date:  2017-10-19       Impact factor: 3.446

3.  Clinical evaluation of cardiac effects of experimental doxycycline overdosing in healthy calves.

Authors:  Mounir Brihoum; Frédéric Rollin; Daniel Desmecht; Johann Detilleux; Hélène Amory
Journal:  BMC Vet Res       Date:  2011-07-25       Impact factor: 2.741

4.  Maduramicin arrests myocardial cells at G0/G1 phase of the cell cycle through inhibiting AKT-Cyclin D1 signaling.

Authors:  Xin Chen; Chang Liu; Meng Zhang; Yumei Zhang
Journal:  3 Biotech       Date:  2021-06-20       Impact factor: 2.893

5.  Maduramicin inhibits proliferation and induces apoptosis in myoblast cells.

Authors:  Xin Chen; Ying Gu; Karnika Singh; Chaowei Shang; Mansoureh Barzegar; Shanxiang Jiang; Shile Huang
Journal:  PLoS One       Date:  2014-12-22       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.